Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Salix Pharmaceuticals, Ltd. 

1700 Perimeter Park Drive

Morrisville  North Carolina  27560  U.S.A.
Phone: 919-862-1000 Fax: 919-862-1095



 Company News
Salix Pharmaceuticals, Ltd. (SLXP) Announces 2Q2014 Financial Results Conference Call And Webcast 7/24/2014 12:56:43 PM
Pharming Group (PHGUF.PK), Salix Pharmaceuticals, Ltd. (SLXP) Wins FDA Approval For Ruconest® 7/17/2014 8:27:12 AM
FDA Office Of Drug Evaluation III Approves Salix Pharmaceuticals, Ltd. (SLXP)’s Request That The FDA Approve The RELISTOR® Subcutaneous Injection sNDA For The Treatment Of Opioid-Induced Constipation In Patients With Chronic Non-Cancer Pain 7/14/2014 11:32:00 AM
Salix Pharmaceuticals, Ltd. (SLXP) Scoops Up Cosmo Technologies For Tax Savings 7/9/2014 8:41:55 AM
Salix Pharmaceuticals, Ltd. (SLXP) Surges On Encouraging Phase 3 Results For Rifaximin; Stock Up +13.51% At Market Close (July 1, 2014) 7/1/2014 8:10:23 AM
Salix Pharmaceuticals, Ltd. (SLXP) To Host Investor Day On July 9, 2014 6/25/2014 7:23:49 AM
Salix Pharmaceuticals, Ltd. (SLXP) Release: FDA Ad Comm Provides Recommendations Regarding The Potential Cardiovascular Risk Associated With The Class Of Peripherally-Active Opioid Receptor Antagonists And The Trials To Support Approval Of Products For OIC 6/13/2014 8:08:46 AM
Salix Pharmaceuticals, Ltd. (SLXP) To Present At Three Investment Conferences In June 5/28/2014 7:27:07 AM
Salix Pharmaceuticals, Ltd. (SLXP) Reports 1Q2014 Results 5/9/2014 7:56:57 AM
Salix Pharmaceuticals, Ltd. (SLXP) To Present At Two Investment Conferences In May 5/6/2014 7:59:50 AM